Clearbridge Health (SGX:1H3) received a listing and quotation notice from the SGX for the listing and quotation of up to 1,279,125,560 rights shares, according to a filing with the Singapore Exchange on Monday.
The medical services company had earlier proposed a rights issue at an issue price of SG$0.002 per rights share.
Proceeds from the issuance worth between SG$515,000 and SG$2.3 million will be used for general working capital needs.
Price (SGD): S$18567.19, Change: S$+49, Percent Change: +0.26%
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。